ATE505539T1 - Verfahren zur förderung des überlebens und/oder der proliferation einer neuralen stammzelle und zur förderung der neuritenverlängerung, promotor dafür, die neurale stammzelle enthaltende pharmazeutische zusammensetzung, testverfahren und screening-verfahren - Google Patents
Verfahren zur förderung des überlebens und/oder der proliferation einer neuralen stammzelle und zur förderung der neuritenverlängerung, promotor dafür, die neurale stammzelle enthaltende pharmazeutische zusammensetzung, testverfahren und screening-verfahrenInfo
- Publication number
- ATE505539T1 ATE505539T1 AT04787726T AT04787726T ATE505539T1 AT E505539 T1 ATE505539 T1 AT E505539T1 AT 04787726 T AT04787726 T AT 04787726T AT 04787726 T AT04787726 T AT 04787726T AT E505539 T1 ATE505539 T1 AT E505539T1
- Authority
- AT
- Austria
- Prior art keywords
- neural stem
- stem cells
- stem cell
- methods
- proliferation
- Prior art date
Links
- 210000001178 neural stem cell Anatomy 0.000 title abstract 13
- 238000000034 method Methods 0.000 title abstract 7
- 230000035755 proliferation Effects 0.000 title abstract 5
- 230000004083 survival effect Effects 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 238000012216 screening Methods 0.000 title abstract 2
- 230000001737 promoting effect Effects 0.000 title 2
- 238000012360 testing method Methods 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 abstract 3
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 102000000795 Galectin 1 Human genes 0.000 abstract 1
- 108010001498 Galectin 1 Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000012911 assay medium Substances 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 238000010899 nucleation Methods 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/59—Lectins
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003317379 | 2003-09-09 | ||
PCT/JP2004/013043 WO2005026343A1 (ja) | 2003-09-09 | 2004-09-08 | 神経幹細胞の生存及び/又は増殖及び神経突起伸張を促進する方法並びに促進剤、神経幹細胞を含む医薬組成物、検定方法、スクリーニング方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE505539T1 true ATE505539T1 (de) | 2011-04-15 |
Family
ID=34308479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04787726T ATE505539T1 (de) | 2003-09-09 | 2004-09-08 | Verfahren zur förderung des überlebens und/oder der proliferation einer neuralen stammzelle und zur förderung der neuritenverlängerung, promotor dafür, die neurale stammzelle enthaltende pharmazeutische zusammensetzung, testverfahren und screening-verfahren |
Country Status (6)
Country | Link |
---|---|
US (1) | US7785596B2 (de) |
EP (1) | EP1674566B1 (de) |
JP (2) | JP5099288B2 (de) |
AT (1) | ATE505539T1 (de) |
DE (1) | DE602004032248D1 (de) |
WO (1) | WO2005026343A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4997432B2 (ja) * | 2006-02-10 | 2012-08-08 | 学校法人慶應義塾 | 神経幹細胞の増殖抑制剤 |
JP4925262B2 (ja) * | 2006-04-05 | 2012-04-25 | 学校法人慶應義塾 | シグナル伝達系活性化剤 |
WO2008036717A2 (en) * | 2006-09-19 | 2008-03-27 | Emory University | Use of soluble galectin-3 (gal-3) for cancer treatment |
AU2007326171B2 (en) | 2006-11-30 | 2012-11-15 | Medipost Co., Ltd. | Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells |
CA2676323A1 (en) * | 2007-01-18 | 2008-07-24 | Suomen Punainen Risti, Veripalvelu | Novel methods and reagents directed to production of cells |
US20100120142A1 (en) | 2008-07-11 | 2010-05-13 | Suomen Punainen Risti Veripalvelu | Culture of human embryonic cells |
EP2315828B1 (de) * | 2008-07-11 | 2015-07-01 | Glykos Finland Oy | Verfahren zur Kultivierung von induzierten pluripotenten Stammzellen mit einem Lektin |
KR20100054711A (ko) | 2008-11-14 | 2010-05-25 | 메디포스트(주) | 간엽 줄기세포 또는 이의 배양액을 포함하는 신경질환의 예방 또는 치료용 조성물 |
JP2012029684A (ja) * | 2010-06-30 | 2012-02-16 | Cell Aid Kenkyusho:Kk | 細胞の製造方法 |
US9694049B2 (en) * | 2011-08-11 | 2017-07-04 | Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The Unitversity Of Nevada, Reno | Methods for treating muscular dystrophy |
BR112017022715A2 (pt) | 2015-04-21 | 2018-07-17 | Consejo Nacional De Investigaciones Cientificas Y Tecn Conicet | variante do polipeptídeo gal-1, ácido nucleico, composição farmacêutica, método para modular uma resposta imunológica e método para tratamento de um sujeito |
JP2019537432A (ja) | 2016-10-04 | 2019-12-26 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | 標的化エフェクタータンパク質およびその使用 |
US11407797B2 (en) | 2017-10-11 | 2022-08-09 | University Of Florida Research Foundation, Incorporated | Modified gal-1 proteins and uses thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750376A (en) * | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
US5968829A (en) * | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
EP1122311A4 (de) * | 1998-07-31 | 2002-04-17 | Kirin Brewery | Heilverfahren der neuropathie, welche als aktiven inhaltsstoff galektin-1 oder seine derivate beinhalten |
US6436389B1 (en) * | 1998-12-11 | 2002-08-20 | The Salk Institute For Biological Studies | Stimulation of cell proliferation by glycosylated cystatin C |
EP1302533A4 (de) * | 2000-05-16 | 2004-11-17 | Kyowa Hakko Kogyo Kk | Neue methode zur induktion der differenzierung von embryonalen stammzellen in ektodermale zellen und deren verwendungen |
EP1425297B1 (de) * | 2001-04-20 | 2009-01-07 | Children's Hospital Of Orange County | Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkern |
JP2002325571A (ja) * | 2001-04-27 | 2002-11-12 | Purotekku:Kk | 網膜の分化誘導方法 |
JP3566941B2 (ja) * | 2001-05-31 | 2004-09-15 | 独立行政法人 科学技術振興機構 | MusashiによるNumbタンパク質発現抑制剤 |
CN1458273A (zh) * | 2002-01-16 | 2003-11-26 | 中国医学科学院中国协和医科大学血液学研究所 | 人胎儿背根神经节干细胞的分离、制备及应用 |
US8043853B2 (en) * | 2002-08-14 | 2011-10-25 | The Regents Of The University Of Michigan | Postnatal gut neural crest stem cells |
EP1540348A4 (de) * | 2002-08-27 | 2006-10-11 | Stemcells California Inc | Angereicherte stammzellen- und vorläuferzellpopulationen des zentralen nervensystems und identifizierungs-, isolierungs- und anreicherungsverfahren für solche populationen |
-
2004
- 2004-09-08 US US10/571,277 patent/US7785596B2/en not_active Expired - Fee Related
- 2004-09-08 AT AT04787726T patent/ATE505539T1/de not_active IP Right Cessation
- 2004-09-08 EP EP04787726A patent/EP1674566B1/de not_active Not-in-force
- 2004-09-08 JP JP2005513873A patent/JP5099288B2/ja not_active Expired - Fee Related
- 2004-09-08 DE DE602004032248T patent/DE602004032248D1/de active Active
- 2004-09-08 WO PCT/JP2004/013043 patent/WO2005026343A1/ja active Application Filing
-
2012
- 2012-01-11 JP JP2012003320A patent/JP2012077092A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1674566B1 (de) | 2011-04-13 |
EP1674566A4 (de) | 2007-01-17 |
JPWO2005026343A1 (ja) | 2007-11-08 |
US7785596B2 (en) | 2010-08-31 |
DE602004032248D1 (de) | 2011-05-26 |
JP5099288B2 (ja) | 2012-12-19 |
US20070098701A1 (en) | 2007-05-03 |
JP2012077092A (ja) | 2012-04-19 |
EP1674566A1 (de) | 2006-06-28 |
WO2005026343A1 (ja) | 2005-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE505539T1 (de) | Verfahren zur förderung des überlebens und/oder der proliferation einer neuralen stammzelle und zur förderung der neuritenverlängerung, promotor dafür, die neurale stammzelle enthaltende pharmazeutische zusammensetzung, testverfahren und screening-verfahren | |
Ohlendieck et al. | Nitrogen fixation by diazotrophic cyanobacteria in the Baltic Sea and transfer of the newly fixed nitrogen to picoplankton organisms | |
AR053272A1 (es) | Determinacion de responsivos a la quimioterapia | |
ATE480615T1 (de) | Verfahren zur proliferation von stammzellen | |
Osathanon et al. | Cobalt chloride supplementation induces stem-cell marker expression and inhibits osteoblastic differentiation in human periodontal ligament cells | |
GB2436737B (en) | Culture medium containing kinase inhibitors,and uses thereof | |
Glas et al. | Calcification acidifies the microenvironment of a benthic foraminifer (Ammonia sp.) | |
BR112012014925A2 (pt) | compostos promotores de replicação de células beta e métodos de uso dos mesmos | |
BRPI0514680A (pt) | produção de anticorpos anti-amilóide beta | |
UA116618C2 (uk) | СКОНСТРУЙОВАНЕ НА ОСНОВІ ЦИСТЕЇНУ АНТИТІЛО ПРОТИ CD79b | |
IL188874A0 (en) | APOPTOSIS SENSIVITY TO AP02L/TRAIL BY TESTING FOR GalNac -T14 EXPRESSION IN CELLS/TISSUES | |
Oleksy et al. | Nutrients and warming alter mountain lake benthic algal structure and function | |
HK1093755A1 (en) | Method for differentiating mesenchymal stem cell into neural cell | |
WO2012131733A3 (en) | Media compositions for enriching cultures of stem cells | |
DE602007013695D1 (de) | Leuchtende stammzellen und ihre verwendung | |
ATE551358T1 (de) | Verfahren und zusammensetzungen zur modulierung des hepatozytenwachstums, der differenzierung von plasmazellen oder der aktivität von t-zellen durch modulierung der aktivität von xbp-1 | |
Vannini et al. | Identification of in vitro HSC fate regulators by differential lipid raft clustering | |
ZA200807766B (en) | Inhibition of GASC1 | |
EP1670902A4 (de) | Verfahren und zusammensetzung zur verbesserung der embryoentwicklung in vitro durch ergänzen des kulturmediums mit prostaglandin oder einem prostaglandinanalogen | |
Bianchi et al. | Microbial activities at the benthic boundary layer in the Aegean Sea | |
FR2894594B1 (fr) | Test predictif de reponse therapeutique du cancer du sein | |
ATE552333T1 (de) | Follikular flüssigkeit für verlängertes wachstum und überleben der zellen für zelltherapien | |
EP2586874A4 (de) | Verfahren zum screening auf s1p-lyase-hemmer mit kultivierten zellen | |
Genkai-Kato et al. | Photosynthetic potential of phytoplankton in the deep water of Lake Baikal, Russia | |
WO2010056012A3 (en) | Method for quantifying skin changes caused by six external evils and method for screening skin condition-improving materials using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |